Qasim Rafiq
Associate Professor in Cell and Gene Therapy Bioprocess Engineering at University College London
Meet Qasim Rafiq
“As a biochemical engineer by training, I would expect the delivery of cell and gene therapies to be underpinned by robust and scalable bioprocesses and innovative manufacturing technologies,” says Rafiq. “To ensure the sector’s continued growth, it is now at a critical juncture where it needs to demonstrate sustained value and commercial viability. This can only be achieved through improved standardized, scalable and robust manufacturing processes. In brief, advanced therapies need to be industrialized.”